Matsumoto Takuya 松本卓也

Researcher Number	70724780
Other IDs
Affiliation (Current)	2025: 愛媛大学, 医学部附属病院, 講師
Affiliation (based on the past Project Information) *help	2021 – 2023: 愛媛大学, 医学部附属病院, 講師 2015 – 2019: 愛媛大学, 医学部附属病院, 講師(病院教員) 2014: 愛媛大学, 医学部附属病院, 助教(病院教員)
Review Section/Research Field	Principal Investigator Collagenous pathology/Allergology / Basic Section 54020:Connective tissue disease and allergy-related
Keywords	Principal Investigator Cキナーゼ阻害剤 / 免疫寛容樹状細胞 / 制御性Ｔ細胞 / Ｃキナーゼ阻害剤 / Cキナーゼ阻害薬 / miRNA / T細胞エピトープ

Study of tolerogenic dendritic cells and application of the cells to collagen diseasesPrincipal Investigator
- Principal Investigator
  
  Matsumoto Takuya
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54020:Connective tissue disease and allergy-related
- Research Institution
  Ehime University
Study of antigen-specific immunosuppressive therapy using tolerogenic dendritic cells induced by protein kinase C inhibitorPrincipal Investigator
- Principal Investigator
  
  Matsumoto Takuya
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  Ehime University
Development of the treatment for autoimmune disorders using human tolerogenic dendritic cells induced by protein kinase C inhibitor.Principal Investigator
- Principal Investigator
  
  Matsumoto Takuya
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  Ehime University

All 2022 2021 2019 2018 2017 2016 2015 2014 Other

All Journal Article Presentation Other

[Journal Article] A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy2022
- Author(s)
  Hiraoka D, Ishizaki J, Horie K, Matsumoto T, Suemori K, Takenaka K, Hasegawa H.
- Journal Title
  
  Modern Rheumatology Case Report .
  
  Volume: 24;6:(2) Issue: 2 Pages: 194-198
- DOI
  10.1093/mrcr/rxab054
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K08459
[Journal Article] Giant Cell Arteritis Presenting with Ptosis and Diplopia2021
- Author(s)
  Hiraoka D, Ishizaki J, Horie K, Matsumoto T, Suemori K, Takenaka K, Hasegawa H.
- Journal Title
  
  Intern. Med.
  
  Volume: 60 Issue: 14 Pages: 2333-2336
- DOI
  10.2169/internalmedicine.6521-20
- NAID
  130008065214
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2021-07-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08931, KAKENHI-PROJECT-21K08459
[Journal Article] Mechanisms of tolerance induction by dendritic cells in vivo.2018
- Author(s)
  Hasegawa H, Matsumoto T
- Journal Title
  
  Frontiers in Immunology
  
  Volume: 9 Pages: 350-350
- DOI
  10.3389/fimmu.2018.00350
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K09551, KAKENHI-PROJECT-17K16208
[Journal Article] Cキナーゼ阻害剤で誘導されたヒト免疫寛容樹状細胞による自己免疫疾患への展開2017
- Author(s)
  松本卓也，長谷川均
- Journal Title
  
  アレルギーの臨床
  
  Volume: 37(13) Pages: 49-54
- Data Source
  KAKENHI-PROJECT-17K16208
[Journal Article] Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction2016
- Author(s)
  Adnan E, Yasukawa M, et al.
- Journal Title
  
  Clin Immunol.
  
  Volume: 173 Pages: 96-108
- DOI
  10.1016/j.clim.2016.09.007
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15H04858, KAKENHI-PROJECT-26860752, KAKENHI-PROJECT-15K09551
[Journal Article] 樹状細胞のトレランス誘導機能とprotein kinase C2014
- Author(s)
  長谷川均、松本卓也、安川正貴
- Journal Title
  
  臨床免疫・アレルギー科
  
  Volume: 61 Pages: 141-150
- Data Source
  KAKENHI-PROJECT-26860752
[Presentation] ANCA関連血管炎の寛解導入および寛解維持期における疾患活動性マーカーとしての血清ＴIMP1値の有用性の検討2019
- Author(s)
  石崎淳、松本卓也、末盛浩一郎、佐田榮司、長谷川均、竹中克斗
- Organizer
  日本リウマチ学会
- Data Source
  KAKENHI-PROJECT-17K16208
[Presentation] 当院におけるＡＮＣＡ関連血管炎性中耳炎（ＯＭＡＡＶ）の臨床的検討2019
- Author(s)
  末盛浩一郎、石崎淳、松本卓也、佐田榮司、竹中克斗、長谷川均
- Organizer
  日本リウマチ学会
- Data Source
  KAKENHI-PROJECT-17K16208
[Presentation] Ｃキナーゼ阻害剤で誘導されたヒト寛容型樹状細胞の特徴と自己免疫疾患からの誘導2018
- Author(s)
  長谷川均、松本卓也、石崎淳、末盛浩一郎
- Organizer
  第62回日本リウマチ学会
- Data Source
  KAKENHI-PROJECT-17K16208
[Presentation] Characterization of human tolerogenic dendritic cells generated with protein kinase C inhibitor and induction from patients with autoimmune diseases.2017
- Author(s)
  Hasegawa, H., Matsumoto, T., Adnan, E., Ishizaki, J., Suemori, K., Yasukawa, M.
- Organizer
  2017 ACR/ARHP Annual Meeting.San Diego, U.S.A. 2017.11.6.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16208
[Presentation] 各種誘導物質で誘導された免疫寛容樹状細胞の抑制機能の比較検討2015
- Author(s)
  長谷川均、Endy Adnan、松本卓也、石崎淳、大西佐知子、末盛浩一郎、安川正貴
- Organizer
  第43回日本臨床免疫学会総会
- Place of Presentation
  神戸国際会議場(兵庫県神戸市)
- Year and Date
  2015-10-22
- Data Source
  KAKENHI-PROJECT-26860752
[Presentation] Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for regulatory T cell induction- A comparative study2014
- Author(s)
  Endy adnan, Takuya Matsumoto, et al
- Organizer
  Annual Scientific Meeting of the American Collage of Rheumatology
- Place of Presentation
  Boston, USA
- Year and Date
  2014-11-18
- Data Source
  KAKENHI-PROJECT-26860752
[Presentation] プロテインキナーゼC阻害剤誘導免疫寛容樹状細胞の生体での効果と他の免疫寛容樹状細胞との比較
- Author(s)
  松本卓也、大西佐知子、石崎淳、末盛浩一郎、安川正貴、長谷川均
- Organizer
  第５８回日本リウマチ学会
- Place of Presentation
  東京, 日本
- Year and Date
  2014-04-24 – 2014-04-26
- Data Source
  KAKENHI-PROJECT-26860752
[]

1. HASEGAWA Hitoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. 安川正貴

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Matsumoto Takuya 松本 卓也

Research Projects

Research Products

Co-Researchers

Study of tolerogenic dendritic cells and application of the cells to collagen diseasesPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Study of antigen-specific immunosuppressive therapy using tolerogenic dendritic cells induced by protein kinase C inhibitorPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of the treatment for autoimmune disorders using human tolerogenic dendritic cells induced by protein kinase C inhibitor.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A case of clinically amyopathic dermatomyositis that was refractory to intensive immunosuppressive therapy including tofacitinib, but successfully treated with plasma exchange therapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Giant Cell Arteritis Presenting with Ptosis and Diplopia2021

Author(s)

Journal Title

DOI

NAID

ISSN

Year and Date

Language

Data Source

[Journal Article] Mechanisms of tolerance induction by dendritic cells in vivo.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cキナーゼ阻害剤で誘導されたヒト免疫寛容樹状細胞による自己免疫疾患への展開2017

Author(s)

Journal Title

Data Source

[Journal Article] Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] 樹状細胞のトレランス誘導機能とprotein kinase C2014

Author(s)

Journal Title

Data Source

[Presentation] ANCA関連血管炎の寛解導入および寛解維持期における疾患活動性マーカーとしての血清ＴIMP1値の有用性の検討2019

Author(s)

Organizer

Data Source

[Presentation] 当院におけるＡＮＣＡ関連血管炎性中耳炎（ＯＭＡＡＶ）の臨床的検討2019

Author(s)

Organizer

Data Source

[Presentation] Ｃキナーゼ阻害剤で誘導されたヒト寛容型樹状細胞の特徴と自己免疫疾患からの誘導2018

Author(s)

Organizer

Data Source

[Presentation] Characterization of human tolerogenic dendritic cells generated with protein kinase C inhibitor and induction from patients with autoimmune diseases.2017

Author(s)

Organizer

Data Source

[Presentation] 各種誘導物質で誘導された免疫寛容樹状細胞の抑制機能の比較検討2015

Author(s)

Organizer

Place of Presentation

Year and Date

Data Source

[Presentation] Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for regulatory T cell induction- A comparative study2014

Author(s)

Organizer

Place of Presentation

Matsumoto Takuya 松本卓也